Topographical Model of MS: a reconceptualization of Multiple Sclerosis clinical course

Dr Stephen Krieger describes the topographical model of MS

Dr. Krieger reports consulting or advisory work with Biogen, EMD Serono, Genentech, Genzyme, Mallinckrodt, MedDay, Novartis, Teva, and TG Therapeutics, and non-promotional speaking with Biogen, EMD Serono, Genentech, and Novartis. Grant and research support from Biogen and Novartis.